ClinicalTrials.gg
CompletedNCT05360199Updated May 4, 2022

Are Postoperative Patient PROMS Influenced by Recall of Preoperative Scores?

An interventional study of PROMs in Degenerative Diseases, Spinal Cord, sponsored by Centro Hospitalar De São João, E.P.E.. Completed at 2 sites in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-04.

Sponsored by Centro Hospitalar De São João, E.P.E. · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jan 2021, registered Apr 2022).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
236
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

To evaluate whether postoperative PROM scores of spine patients are influenced by memory bias

02

Conditions studied

  • Degenerative Diseases, Spinal Cord

Keywords

  • PROM
  • Recall bias
03

In context

Neurodegenerative Diseases

436 studies on the registry are indexed under Neurodegenerative Diseases; 143 are open to participants now.

This study's enrollment of 236 is above the median of 54 across 265 interventional studies indexed under Neurodegenerative Diseases.

Browse Neurodegenerative Diseases studies →

Lead sponsor

Centro Hospitalar De São João, E.P.E. is the lead sponsor of 12 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All adult patients with valid preoperative PROM scores submitted to spine surgery due to degenerative pathology from January 2019 to April 2020 at our center (spine unit of a neurosurgical department in a Portuguese university hospital) were included in the study and received PROMs questionnaires with a letter of consent.

Exclusion criteria

Exclusion Criteria:

  • Patients without valid preoperative questionnaires were excluded from the study while patients were lost to follow-up if mail questionnaires were not completed two months after PROMs remittance or if they had submitted incomplete or invalid answers.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
236 participants (actual)

Study arms

  • No intervention
    control group

    no recall PROMs group ; without knowledge of previous PROMs scores

  • Active comparator
    intervention group

    recall PROMs group ; with knowledge of previous PROMs scores

    Behavioral: PROMs

Interventions

  • BehavioralPROMs

    evaluate the impact of recall bias on post proms scores

06

What researchers measure

Primary outcomes

  1. Median COMI score results

    Core outcome measures index. Scale 0 to 10 where 0 means the best score

    Time frame: 4 weeks

Secondary outcomes

  1. Median ODI score

    Neck disability index Oswestry disability index. Scale 0 to 100 where 0 means the worst score

    Time frame: 4 weeks

  2. Median EQ-5D score

    EuroQol 5 D where 1 is the best score and -0,500 the worst score

    Time frame: 4 weeks

  3. Median NDI

    Neck disability index Scale 0 to 100 where 0 means the worst score

    Time frame: 4 weeks

07

Study locations

2 sites
  • Centro Hospitalar Universitário São João
    Porto, Portugal
  • Centro Hospitalar Universitário São João
    Portugal, Portugal
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2021 to primary completion in Sep 2021, 8 months.

Of 75 non-industry interventional studies with no phase under Neurodegenerative Diseases, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 57. This study's 8 months is below that.

Counting every sponsor, half of 82 studies reached it within 35 months; a quarter within 11 and three quarters within 67.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2022
First posted
May 4, 2022
StartActual
Jan 1, 2021
Primary completionActual
Sep 15, 2021
CompletionActual
Oct 15, 2021
Last update
May 4, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05360199
Lead sponsor
Centro Hospitalar De São João, E.P.E.
Responsible party
Pedro Daniel Valente Aguiar (Doctor, Centro Hospitalar De São João, E.P.E.) — Principal investigator
First posted
May 4, 2022
Start date
Jan 1, 2021
Primary completion
Sep 15, 2021
Completion
Oct 15, 2021
Last update
May 4, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion